Missing/wrong data?
Log in to edit
Phase I evaluation of seliciclib (R-roscovitine), a novel oral cyclin-dependent kinase inhibitor, in patients with advanced malignancies
scientific article published on 6 September 2010
Author/s
author: Sandrine Faivre, Sheelagh Frame
Work details
Publication date
September 6, 2010
-
-
Language
English
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.